Jemperli (dostarlimab) in combination with chemotherapy (carboplatin and paclitaxel) for first-line treatment of adult ...

We recently published a list of 12 Undervalued Defensive Stocks for 2025. In this article, we are going to take a look at ...

Drugmakers are growing frustrated with the National Health Service after a clawback tax unexpectedly soared, with ...

GSK’s share price has been pressured recently from several negative events, but this may leave a bargain to be had. I've ...

The pipeline will run for about 213 kilometres to a $7.4 billion polyethylene plant where construction started last September ...

In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against other undervalued defensive Stocks for 2025. The consumer defensive sector covers products that everyone ...

Teva Pharmaceutical Industries Ltd. ADR-0.95% $24.61B ...

The scrubbing of clinical trial-related pages is notable because of how it could affect the ways researchers both inside and ...

GSK has reached an agreement that it says will resolve 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. The company has ...